share_log

HC Wainwright & Co. Maintains Buy on Ekso Bionics Holdings, Lowers Price Target to $9.25

Benzinga ·  Mar 5, 2024 23:38

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy and lowers the price target from $10 to $9.25.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment